Our July issue is live! Read more about deuterium in drug discovery, amplifying gene expression with RNA-targeted therapies, accelerating antiviral discovery, including African data in drug R&D, RSV vaccines and more here https://t.co/tYE8LNRYuJ
Deuterium in drug discovery: progress, opportunities and challenges https://t.co/4SyMwWfrkP
A new review by @RitaMariaConce2 , Brad Maxwell and @TraceyPirali discussing how deuteration may improve the pharmacokinetic and/or toxicity profile of drugs (link corrected)
Deuterium in drug discovery: progress, opportunities and https://t.co/guG0GAprJD
A new review by @RitaMariaConce2 , Brad Maxwell and @TraceyPirali discussing how deuteration may improve the pharmacokinetic and/or toxicity profile of drugs
A Versatile and Sustainable Multicomponent Platform for the Synthesis of Protein Degraders: Proof-of-Concept Application to BRD4-Degrading PROTACs https://t.co/qbBLy933rv
ARN15381 is very much alive and kicking. Very nice results reported in this study coordinated by Nazzareno Cannella.
The multitarget FAAH inhibitor/D3 partial agonist ARN15381 decreases n... https://t.co/w16vvEwuFZ
Born #OnThisDay in 1909, Rita Levi-Montalcini studied how nerves grow and won a Nobel Prize for her work https://t.co/vVKRM6pWtp #histsci (Image by audrey_sel via Wikimedia Commons)
Open postdoctoral position to join the Computer-assisted Molecular Design Lab at the Department of Biomolecular Sciences (DISB) of the University of Urbino.
Just a few days left, deadline April 15th
https://t.co/8nVniA6Ymv
Exciting project in collaboration with a pharma company.
Open postdoctoral position to join the Computer-assisted Molecular Design Lab at the Department of Biomolecular Sciences (DISB) of the University of Urbino
Apply at:
https://t.co/8nVniA6Ymv
https://t.co/R86anJ7aM1
Check out our latest patent review on #D3R ligands for therapeutic intervention on CNS-associated disorders, cancer, and other conditions!! @CAMD_DISB
👇👇👇
Massive work by @RitaMariaConce2 on this review paper. Looking forward to new collaborations!
Dopamine D3 receptor ligands: a patent review (2014-2020) https://t.co/Jn8FALy27M